Zhende Medical Financials
| 603301 Stock | 22.66 0.02 0.09% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 422.4 M | 444.6 M |
|
|
Zhende | Select Account or Indicator |
Understanding current and past Zhende Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zhende Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Zhende Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Zhende Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zhende Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zhende Medical's management manipulating its earnings.
Zhende Medical Stock Summary
Zhende Medical competes with Talkweb Information, Digital China, Zhongrun Resources, Xiandai Investment, and AVCON Information. Zhende Medical is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100003J31 |
| Business Address | No 55, Xiangji |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.zhende.com |
| Phone | 86 575 8875 1963 |
You should never invest in Zhende Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Zhende Stock, because this is throwing your money away. Analyzing the key information contained in Zhende Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Zhende Medical Key Financial Ratios
Zhende Medical's financial ratios allow both analysts and investors to convert raw data from Zhende Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Zhende Medical over time and compare it to other companies across industries.| Revenue | 4.13 B | ||||
| Gross Profit | 1.74 B | ||||
| EBITDA | 462.31 M | ||||
| Net Income | 198.4 M | ||||
| Total Asset | 7.27 B |
Zhende Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Liab | 45.6M | 49.2M | 98.9M | 201.6M | 231.8M | 243.4M | |
| Net Tangible Assets | 959.4M | 1.1B | 3.8B | 3.2B | 3.7B | 3.9B | |
| Retained Earnings | 446.3M | 2.9B | 3.0B | 3.4B | 3.1B | 1.7B | |
| Other Assets | 22.6M | 42.6M | 153.2M | 120.3M | 138.4M | 145.3M | |
| Total Assets | 2.7B | 6.4B | 6.4B | 7.9B | 7.3B | 4.8B | |
| Other Current Liab | 89.4M | 356.8M | 176.3M | 16.9M | 1.4M | 1.4M | |
| Accounts Payable | 289.7M | 636.3M | 576.8M | 702.7M | 412.6M | 436.2M | |
| Cash | 646.2M | 1.8B | 1.4B | 2.1B | 1.1B | 1.0B | |
| Long Term Debt | 424.2M | 95.1M | 145.2M | 388.4M | 200.2M | 179.1M | |
| Net Receivables | 389.7M | 663.7M | 690.4M | 767.9M | 539.6M | 511.6M | |
| Good Will | 89.6M | 130.4M | 398.5M | 474.5M | 787.8M | 827.2M | |
| Inventory | 430.9M | 1.1B | 833.5M | 929.6M | 800.8M | 669.6M | |
| Other Current Assets | 87.2M | 236.2M | 265.6M | 41.0M | 64.1M | 117.2M | |
| Total Liab | 1.3B | 1.9B | 2.0B | 2.1B | 1.7B | 1.5B | |
| Short Long Term Debt | 292.5M | 358.4M | 660.7M | 124.0M | 220.1M | 281.6M | |
| Total Current Assets | 1.6B | 4.4B | 3.2B | 4.1B | 2.7B | 2.5B | |
| Intangible Assets | 185.1M | 225.6M | 444.8M | 564.5M | 607.1M | 323.4M | |
| Net Invested Capital | 2.1B | 4.6B | 4.9B | 6.1B | 5.8B | 4.1B | |
| Net Working Capital | 796.2M | 2.6B | 1.6B | 2.6B | 1.5B | 1.5B |
Zhende Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 24.2M | 18.3M | 25.1M | 33.5M | 28.9M | 18.6M | |
| Income Tax Expense | 21.7M | 22.7M | 561.2M | 99.0M | 113.9M | 119.2M | |
| Minority Interest | 40.9M | 284.1M | (125.1M) | (21.9M) | (15.0M) | (14.3M) | |
| Tax Provision | 22.7M | 561.2M | 99.0M | 100.0M | 5.5M | 5.2M | |
| Net Interest Income | (28.9M) | (10.6M) | (11.5M) | (24.0M) | 9.0M | 9.5M | |
| Interest Income | 1.4M | 12.2M | 15.7M | 10.6M | 40.0M | 42.0M | |
| Total Revenue | 1.9B | 10.4B | 5.1B | 6.1B | 4.1B | 4.3B | |
| Gross Profit | 598.9M | 4.9B | 1.8B | 2.1B | 1.4B | 1.6B | |
| Operating Income | 236.2M | 3.7B | 853.2M | 983.6M | 444.6M | 422.4M | |
| Ebit | 133.8M | 165.2M | 3.6B | 727.2M | 836.3M | 921.1M | |
| Research Development | 51.0M | 259.7M | 153.1M | 227.0M | 138.9M | 132.2M | |
| Cost Of Revenue | 1.3B | 5.5B | 3.3B | 4.0B | 2.7B | 2.7B | |
| Income Before Tax | 199.2M | 3.5B | 819.9M | 801.7M | 218.9M | 207.9M | |
| Net Income | 156.9M | 2.5B | 595.9M | 679.9M | 198.4M | 188.5M | |
| Ebitda | 288.8M | 3.6B | 987.0M | 1.0B | 1.2B | 1.2B |
Zhende Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Zhende Medical. It measures of how well Zhende is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Zhende Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Zhende had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Zhende Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Borrowings | (61.1M) | 487.0M | 11.7M | 343.7M | 395.3M | 415.1M | |
| Capital Expenditures | 273.8M | 1.1B | 695.5M | 754.1M | 599.2M | 482.3M | |
| Change To Netincome | 27.0M | 52.4M | 643.4M | 169.5M | 194.9M | 150.2M | |
| Change To Inventory | (47.4M) | (659.3M) | 279.1M | (228.7M) | (12.7M) | (13.3M) | |
| Change In Cash | 311.2M | 956.3M | (154.6M) | 705.6M | (1.0B) | (965.4M) | |
| Depreciation | 65.3M | 78.6M | 139.3M | 194.3M | 243.0M | 121.8M | |
| Dividends Paid | 58.3M | 78.3M | 543.7M | 164.3M | (423.7M) | (402.5M) | |
| Net Income | 156.9M | 2.5B | 595.9M | 681.1M | 198.4M | 188.5M | |
| End Period Cash Flow | 553.4M | 1.5B | 1.4B | 2.1B | 1.0B | 940.3M | |
| Free Cash Flow | (76.0M) | 2.0B | 122.2M | 491.9M | (147.1M) | (139.8M) | |
| Other Non Cash Items | 21.5M | 113.1M | 40.2M | 12.7M | 18.5M | 29.5M |
Zhende Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zhende Medical's current stock value. Our valuation model uses many indicators to compare Zhende Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zhende Medical competition to find correlations between indicators driving Zhende Medical's intrinsic value. More Info.Zhende Medical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zhende Medical Co is roughly 2.47 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Zhende Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zhende Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Zhende Medical Systematic Risk
Zhende Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zhende Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Zhende Medical correlated with the market. If Beta is less than 0 Zhende Medical generally moves in the opposite direction as compared to the market. If Zhende Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zhende Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zhende Medical is generally in the same direction as the market. If Beta > 1 Zhende Medical moves generally in the same direction as, but more than the movement of the benchmark.
Zhende Medical Co Other Liab Over Time
Zhende Medical Thematic Clasifications
Zhende Medical Co is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Zhende Medical December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Zhende Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zhende Medical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zhende Medical Co based on widely used predictive technical indicators. In general, we focus on analyzing Zhende Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zhende Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.45 | |||
| Information Ratio | 0.0602 | |||
| Maximum Drawdown | 19.14 | |||
| Value At Risk | (2.60) | |||
| Potential Upside | 3.13 |
Complementary Tools for Zhende Stock analysis
When running Zhende Medical's price analysis, check to measure Zhende Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhende Medical is operating at the current time. Most of Zhende Medical's value examination focuses on studying past and present price action to predict the probability of Zhende Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhende Medical's price. Additionally, you may evaluate how the addition of Zhende Medical to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |